Senior Health Home > Risedronate Delayed-Release Drug Information

Risedronate delayed-release (AtelviaTM) is approved for the treatment of osteoporosis in postmenopausal women. This medication is unique in that, unlike other bisphosphonates, you do not need to take it on an empty stomach. In fact, risedronate delayed-release is designed to be taken immediately after breakfast.
Prior to taking this medication, review the safety information for risedronate delayed-release with your healthcare provider. This drug is not suitable for everyone, in particular those with kidney disease or esophageal problems. In addition, drug interactions are possible, so your healthcare provider needs a complete list of all other medicines you are taking, including supplements.
(Click Risedronate Delayed-Release for more information, including how this drug works, general dosing guidelines, possible side effects, and what to do if you take too much.)
Written by/reviewed by:
Last reviewed by: Arthur Schoenstadt, MD
Last updated/reviewed:
List of references (click here):
Other Articles in This eMedTV Presentation

Topics & Medications


Related Channels

eMedTV Links
Copyright © 2006-2020 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.